<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Skip to content

Systemic AML In Vivo Screen 

Advance your AML-targeted programs with 26 clinically relevant patient-derived models, engrafted systemically to preserve unique patient characteristics.

Enrollment now open

 

Request more information on our Systemic AML In Vivo Screen

What Makes This Screen Unique

 Clinically Relevant Models

26 primary AML models engrafted in severely immunodeficient mice, preserving patient biology.

Pretreated PDX Models

Includes models pretreated with Gilteritinib, Mylotarg, experimental FLT3 inhibitors, anti-CD33 ADCs, and stem cell transplants.

Multi-omic Characterization

Full model characterization available in Lumin: clinical data, WES, RNAseq, and standard-of-care assessments.

 Terminal Flow Cytometry

Analysis of peripheral blood and bone marrow (CD3, CD33, CD34, CD38, mCD45, hCD45, CD117, CD123, Viability Dye).

 Optional Endpoint Analysis

Plasma-based Luminex.

Collaborative Benchmarking Arm (Shared SoC)

Clients enrolling in the screen can access cost-shared reference arms to benchmark therapeutic responses while reducing investment.

SoC Agents and Models:
  • 5-Aza: CTG-2227, CTG-2235, CTG-2236, CTG-2239, CTG-2457, CTG-2700, CTG-2702, CTG-3438, 3440 
  • Cytarabine: CTG-2240 
  • Gilteritinib: CTG-2226, CTG-2232, CTG-2233, CTG-2237, CTG-2699, CTG-2704, CTG-3949, CTG-3950, CTG-4130, CTG-4196 
  • Venetoclax: CTG-2228, CTG-2358, CTG-3931, CTG-4052, CTG-4053, CTG-4128
50% off a Standard of Care (SoC) arm, selected by Champions

Collaborative Benchmarking Arm (Shared SoC)

Clients enrolling in the screen can access cost-shared reference arms to benchmark therapeutic responses while reducing investment.

SoC Agents and Models:
  • 5-Aza: CTG-2227, CTG-2235, CTG-2236, CTG-2239, CTG-2457, CTG-2700, CTG-2702, CTG-3438, 3440 
  • Cytarabine: CTG-2240 
  • Gilteritinib: CTG-2226, CTG-2232, CTG-2233, CTG-2237, CTG-2699, CTG-2704, CTG-3949, CTG-3950, CTG-4130, CTG-4196 
  • Venetoclax: CTG-2228, CTG-2358, CTG-3931, CTG-4052, CTG-4053, CTG-4128
50% off a Standard of Care (SoC) arm, selected by Champions
Systemic AML In Vivo Screen Models
 
Our screen includes 26 models annotated with treatment data and analysis of peripheral blood and bone marrow 
 
Model ID
Test Agents
CTG-2226
N/A
CTG-2227
Venetoclax, Gilteritinib, 5-Azacitidine + Venetoclax, Ivosidenib
CTG-2228
Gilteritinib
CTG-2232
N/A
CTG-2233
N/A
CTG-2235
Gilteritinib, Venetoclax, Tipifarnib
CTG-2236
Venetoclax, Cytarabine, Gilteritinib
CTG-2237
Venetoclax
CTG-2239
Venetoclax, Tipifarnib, Gilteritinib, 5-Azacitidine + Venetoclax
CTG-2240
Venetoclax, Gilteritinib, Tipifarnib
CTG-2358
N/A
CTG-2457
Venetoclax, Gilteritinib, 5-Azacitidine + Venetoclax
CTG-2699
N/A
CTG-2700
Venetoclax
CTG-2702
Venetoclax
CTG-2704
Venetoclax
CTG-3438
Venetoclax, Gilteritinib
CTG-3440
Venetoclax, Gilteritinib, Tipifarnib
CTG-3931
N/A
CTG-3949
N/A
CTG-3950
5-Azacitidine + Venetoclax
CTG-4052
N/A
CTG-4053
N/A
CTG-4128
N/A
CTG-4130
N/A
CTG-4196
N/A